Clinical Trials of Adult Stem Cell Terapy in Patients with Ischemic Stroke

키워드

참고문헌 (44)

1. Chopp M, "Treatment of neural injury with marrow stromal cells", Lancet Neurol, 1, pp.92~100 (2002)
2. Chang DJ, "Therapeutic potential of human induced pluripotent stem cells in experimental stroke", Cell Transplant, 22, pp.1427~1440 (2013)
3. Dihné M, "Restoring neuronal function after stroke by cell replacement: anatomic and functional considerations", Stroke, 42, pp.2342~2350 (2011)
4. Chen X, "Ischemic rat brain extracts induce human marrow stromal cell growth factor production", Neuropathology, 22, pp.275~279 (2002)
5. Li WY, "Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing", Cell Transplant, 17, pp.1045~1059 (2008)
6. Liu Z, "Bone marrow stromal cells promote skilled motor recovery and enhance contralesional axonal connections after ischemic stroke in adult mice", Stroke, 42, pp.740~744 (2011)
7. Song M, "Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice", Cell Transplant, 22, pp.2001~2015 (2013)
8. Lai RC, "Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease", Regen Med, 6, pp.481~492 (2011)
9. Lee ST, "Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke", Brain, 131(Pt 3), pp.616~629 (2008)
10. Kim YJ, "Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action", Glia, 57, pp.13~23 (2009)
11. Shen LH, "Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke", J Cereb Blood Flow Metab, 27, pp.6~13 (2007)
12. Shin JY, "Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models", Autophagy, 10, pp.32~44 (2014)
13. Paik MJ, "The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats", Clin Chim Acta, 402, pp.25~30 (2009)
14. Borlongan CV, "Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke", Stroke, 35, pp.2385~2389 (2004)
15. Rosenblum S, "Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation", Stroke, 43, pp.1624~1631 (2012)
16. Yamauchi T, "Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice", PLoS One, 10, pp.e0116009~ (2015)
17. Bang OY, "Autologous mesenchymal stem cell transplantation in stroke patients", Ann Neurol, 57, pp.874~882 (2005)
18. Lee JS, "A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke", Stem Cells, 28, pp.1099~1106 (2010)
19. Honmou O, "Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke", Brain, 134(Pt 6), pp.1790~1807 (2011)
20. Bhasin A, "Autologous mesenchymal stem cells in chronic stroke", Cerebrovasc Dis Extra, 1, pp.93~104 (2011)
21. Suárez-Monteagudo C, "Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study", Restor Neurol Neurosci, 27, pp.151~161 (2009)
22. Battistella V, "Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke", Regen Med, 6, pp.45~52 (2011)
23. Savitz SI, "Intravenous autologous bone marrow mononuclear cells for ischemic stroke", Ann Neurol, 70, pp.59~69 (2011)
24. Friedrich MA, "Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke", Cell Transplant, 21(Suppl 1), pp.S13~S21 (2012)
25. Li ZM, "Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage-a prospective clinical observation", Clin Neurol Neurosurg, 115, pp.72~76 (2013)
26. Prasad K, "Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial", Stroke, 45, pp.3618~3624 (2014)
27. Savitz SI, "Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study", Cerebrovasc Dis, 20, pp.101~107 (2005)
28. Qiao LY, "A two-year follow-up study of cotransplantation with neural stem", progenitor cells and mesenchymal stromal cells in ischemic stroke patients, 2014, pp.23(Suppl 1), S65~S72
29. Adams HP Jr, "Management of patients with stroke: is it time to expand treatment options?", Ann Neurol, 74, pp.4~10 (2013)
30. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants, "Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS):bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke", Stroke, 40, pp.510~515 (2009)
31. Savitz SI, "Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II", Stroke, 42, pp.825~829 (2011)
32. Savitz SI, "Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials", Stroke, 45, pp.634~639 (2014)
33. Pendharkar AV, "Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia", Stroke, 41, pp.2064~2070 (2010)
34. Yang B, "Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke", Stroke, 44, pp.3463~3472 (2013)
35. Eckert MA, "Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke", J Cereb Blood Flow Metab, 33, pp.1322~1334 (2013)
36. Thiel A, "Structural and resting-state brain connectivity of motor networks after stroke", Stroke, 46, pp.296~301 (2015)
37. Burke Quinlan E, "Neural function, injury, and stroke subtype predict treatment gains after stroke", Ann Neurol, 77, pp.132~145 (2015)
38. Ding DC, "Mesenchymal stem cells", Cell Transplant, 20, pp.5~14 (2011)
39. Bakondi B, "CD133 identifies a human bone marrow stem", progenitor cell sub-population with a repertoire of secreted factors that protect against stroke, 2009, pp.17, 1938~1947
40. Wang JA, "Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells", Int J Cardiol, 133, pp.410~412 (2009)
41. Tang YL, "Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression", Circ Res, 104, pp.1209~1216 (2009)
42. Kim SJ, "Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial", Trials, 14, pp.317~ (2013)
43. Jeevanantham V, "Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis", Circulation, 126, pp.551~568 (2012)
44. Prockop DJ, "Are clinical trials with mesenchymal stem", progenitor cells too far ahead of the science? Lessons from experimental hematology, 2014, pp.32, 3055~3061

관련 논문AI추천